Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent

News

China cites ‘backdoor safety risk’ in Nvidia’s H20 AI chip

TechRepublic · 1d
China Investigates NVIDIA’s H20 Chips for Surveillance Risks
NVIDIA has been called in by Chinese regulators over claims that its H20 AI chip poses security risks, putting billions in potential sales at stake.
Reuters on MSN · 2d
Nvidia says its chips have no 'backdoors' after China flags H20 security concerns
Nvidia said on Thursday its products have no "backdoors" that would allow remote access or control after China raised concerns over potential security risks in the firm's H20 artificial intelligence chip.
Interesting Engineering on MSN · 1d
China cites ‘backdoor safety risk’ in Nvidia’s H20 AI chip; company denies allegation
China has summoned Nvidia to address alleged H20 chip security flaws, raising fresh concerns about the AI giant’s China business.
9hon MSN

Did Donald Trump just give China a major advantage on AI?

The Trump administration quietly reversed a policy that tightened restrictions on microchip exports to China, but why the ...
1don MSN

A backlog at the Commerce Department is reportedly stalling Nvidia’s H20 chip licenses

News of a backlog at the U.S. federal department comes less than a week after national security experts urged the Trump ...
ExtremeTech on MSN2d

China Investigates Nvidia's H20 GPUs Over Spying Hardware Claims

Still, Nvidia will need to tread carefully. The CAC can prevent the sales of H20 GPUs in China, whether ongoing policy shifts ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
Feedback
© 2025 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices
  • Consumer Health Privacy